- Vt 6 mL/kg predicted body weight (from measured height), plateau ≤30, driving pressure ≤15.
- PEEP by the PEEP/FiO₂ table; moderate–severe ARDS → higher PEEP. No long recruitment maneuvers.
- P/F <150 on FiO₂ ≥0.6 → prone early, ≥16 h/day. It is the one rescue therapy with a clear mortality benefit.
- Targets: SpO₂ 88–95% (PaO₂ 55–80), pH ≥7.20 — accept a high PaCO₂.
- Treat the cause (sepsis, pneumonia, aspiration, pancreatitis). Look for mimics.
- After shock resolves → conservative fluids. Consider corticosteroids early.
- Refractory hypoxemia → call an ECMO center early (before the patient is too sick to move).
Pathophysiology in 60 seconds
⌄
- Injury — direct (pneumonia, aspiration) or indirect (sepsis) — damages the alveolar epithelium and capillary endothelium.
- The barrier leaks → protein-rich edema, neutrophils and hyaline membranes fill the alveoli. Surfactant is lost → alveoli collapse.
- Three results:
- Shunt → hypoxemia that does not fix with O₂ alone (needs PEEP to re-open alveoli).
- Low compliance → high pressures for small breaths.
- Dead space → high minute ventilation, CO₂ retention.
- Phases: exudative (days 0–7) → proliferative (days 7–21) → fibrotic (some patients; prolonged ventilation).
Injury to the alveolar epithelium and capillary endothelium → protein-rich fluid, neutrophils and hyaline membranes fill the air space; surfactant is lost, so alveoli collapse. Result: shunt (blood passes unventilated alveoli), stiff lungs (low compliance) and dead space.
Imagine a sponge where most holes are full of glue. Only a small part still takes air — the "baby lung." Push a normal-sized breath into it and it over-stretches and tears.
ARDS lungs are not stiff — they are small. A "normal" 10 mL/kg breath goes into a baby-sized lung → overdistension. That is why we set tidal volume by predicted body weight (6 mL/kg) and watch driving pressure. Proning makes ventilation more even and lowers mortality in severe ARDS (PROSEVA).
Ventilator-induced lung injury (VILI)
| Type | Cause | Prevention |
|---|---|---|
| Volutrauma | Too large a breath for the baby lung | Vt 6 mL/kg PBW |
| Barotrauma | High pressure → pneumothorax | Plateau ≤30 |
| Atelectrauma | Alveoli open and close every breath | Enough PEEP |
| Biotrauma | Stretch releases cytokines → multi-organ failure | All of the above |
Diagnosis — Berlin criteria
⌄
| Criterion | Berlin definition (2012) |
|---|---|
| Timing | Within 1 week of a known insult, or new/worse respiratory symptoms |
| Imaging | Bilateral opacities on CXR/CT, not fully explained by effusion, collapse or nodules |
| Origin | Respiratory failure not fully explained by heart failure or fluid overload (echo if no risk factor) |
| Oxygenation | P/F ratio with PEEP or CPAP ≥5 cmH₂O |
| Severity | PaO₂/FiO₂ | Mortality (approx.) |
|---|---|---|
| Mild | 201–300 | ~27% |
| Moderate | 101–200 | ~32% |
| Severe | ≤100 | ~45% |
- Non-intubated ARDS: P/F ≤300 or SpO₂/FiO₂ ≤315 (SpO₂ ≤97%) on HFNC ≥30 L/min or NIV/CPAP ≥5.
- SpO₂/FiO₂ accepted in place of an ABG (only when SpO₂ ≤97%).
- Lung ultrasound accepted for bilateral involvement (trained operator).
- Resource-limited settings: PEEP and flow requirements dropped.
- Intubated severity grades unchanged (mild/moderate/severe as Berlin).
Causes
| Direct (lung) | Indirect (systemic) |
|---|---|
| Pneumonia (bacterial, viral incl. influenza/COVID) | Sepsis (most common) |
| Aspiration of gastric contents | Pancreatitis |
| Inhalation injury, near-drowning | Major trauma, burns |
| Pulmonary contusion | TRALI, massive transfusion |
| Vaping (EVALI) | Drugs (overdose, chemotherapy) |
- Cardiogenic edema (echo, BNP) · diffuse alveolar hemorrhage (falling Hb, BAL bloody) · acute eosinophilic pneumonia (BAL eos >25%, steroid-responsive) · acute interstitial pneumonia / ILD flare · cryptogenic organizing pneumonia · PJP in the immunocompromised · drug-induced pneumonitis (amiodarone, checkpoint inhibitors).
- No clear risk factor → bronchoscopy with BAL often changes therapy.
Workup
⌄
- ABG (P/F), CXR, CT chest if the cause is unclear (and safe to travel).
- Echo: LV function, RV failure (acute cor pulmonale in ~20% of severe ARDS), filling pressures.
- Infection: blood + respiratory cultures, viral PCR, Legionella/pneumococcal urine antigen, procalcitonin.
- Lipase, CBC, lactate, BNP; BAL if no obvious cause.
- Every day: P/F, plateau pressure, driving pressure, fluid balance.
Management
⌄
Predicted body weight (use measured height): - Men: 50 + 2.3 × (height in inches − 60) - Women: 45.5 + 2.3 × (height in inches − 60)
| Parameter | Target |
|---|---|
| Tidal volume | 6 mL/kg PBW (range 4–8) |
| Plateau pressure | ≤30 cmH₂O (inspiratory hold 0.5 s) |
| Driving pressure (Pplat − PEEP) | ≤15 |
| RR | Up to 35 |
| pH | ≥7.20–7.25 (permissive hypercapnia) |
| SpO₂ / PaO₂ | 88–95% / 55–80 mmHg |
ARDSNet lower PEEP/FiO₂ table:
| FiO₂ | 0.3 | 0.4 | 0.5 | 0.6 | 0.7 | 0.8 | 0.9 | 1.0 |
|---|---|---|---|---|---|---|---|---|
| PEEP | 5 | 5–8 | 8–10 | 10 | 10–14 | 14 | 14–18 | 18–24 |
Moderate–severe ARDS: the higher PEEP/FiO₂ table is suggested (2024 ATS) — check that plateau and driving pressure stay in range and BP holds.
- Who: P/F <150, FiO₂ ≥0.6, PEEP ≥5 — after 12–24 h of stabilization. Earlier is better.
- How long: ≥16 h/day; continue daily until P/F ≥150 with PEEP ≤10, FiO₂ ≤0.6 for ≥4 h supine.
- Benefit: 28-day mortality 16% vs 33% (PROSEVA).
- Team of 5: airway person at the head leads. Secure ETT, lines, chest tubes. Pre-oxygenate 100%.
- Prevent harm: eye care (lubricant, taping), pressure-point padding (face, knees, chest), arms in "swimmer" position, tube feeds can continue (reverse Trendelenburg).
- Relative contraindications: unstable spine, open abdomen/chest, raised ICP, late pregnancy, massive hemoptysis.
- Corticosteroids (2024 ATS, conditional): early moderate–severe ARDS. Options: dexamethasone 20 mg IV daily ×5 d → 10 mg ×5 d (DEXA-ARDS) or methylprednisolone ~1 mg/kg/day with taper. Avoid starting late (>14 days). Screen for strongyloides in endemic exposure.
- Neuromuscular blockade (conditional): early severe ARDS with dyssynchrony despite deep sedation — cisatracurium, 24–48 h. Not routine (ROSE).
- Conservative fluids once out of shock (FACTT): diuretics to even/negative balance → more ventilator-free days.
- No benefit: routine inhaled NO, β-agonists, statins, surfactant.
- Treat the cause: antibiotics, source control, stop the offending drug.
- Target light sedation once stable (RASS 0 to −2); propofol/dexmedetomidine over benzodiazepines; analgesia first (fentanyl).
- Deep sedation only for proning, NMB, severe dyssynchrony.
- Daily SAT + SBT once FiO₂ ≤0.5 and PEEP ≤8.
- Early mobility, delirium screen (CAM-ICU), VAP bundle (head of bed 30°, oral care, subglottic suction).
Doses are typical adult doses. Adjust sedatives and steroids for organ function, and follow your ICU protocol.
Real-life ICU tips
⌄
- Measure the height. Do not trust the stated or estimated height. A 4-inch error changes Vt by ~50 mL. Write the Vt in mL in the order, not just "6 mL/kg."
- Check a plateau every shift and after every vent change — not just peak pressure. Peak high + plateau normal = airway problem (secretions, kink, bronchospasm). Both high = lung/chest wall problem (worse ARDS, pneumothorax, abdominal compartment, mainstem intubation).
- Driving pressure tells you more than P/F. If raising PEEP lowers driving pressure → you recruited lung. If driving pressure rises → you overdistended.
- Double-triggering (two breaths stacked, Vt doubles) is common at 6 mL/kg: deepen sedation/analgesia, increase inspiratory time, or allow Vt up to 7–8 if plateau is still ≤30.
- Sudden desaturation? Bag on 100% → DOPE (Displacement, Obstruction, Pneumothorax, Equipment) → check ETT depth, suction, POCUS for lung sliding.
- High PaCO₂ is OK if pH ≥7.20 and no raised ICP, RV failure or severe acidosis. Raise RR before raising Vt; shorten the circuit (remove HME/extra tubing → less dead space).
- Watch the RV. Hypercapnia, high PEEP and hypoxia stress the RV. Echo: dilated RV, septal flattening → lower PEEP/plateau, fix CO₂, prone, consider inhaled pulmonary vasodilator, norepinephrine.
- Prone before the CT. Transport of a severe ARDS patient is dangerous. Do not delay proning for imaging.
- Call ECMO early. The referral is a phone call — not a commitment. Patients >7 days on high pressures or with multi-organ failure do worse.
- Talk to the family early: ARDS survivors often have weakness, cognitive problems and PTSD (post-ICU syndrome). Plan follow-up.
Pitfalls
⌄
- Using actual body weight for tidal volume (obese patients get huge breaths).
- Chasing P/F with FiO₂ 100% for days instead of PEEP/proning.
- Liberal fluids after shock is over.
- Missing a mimic (DAH, eosinophilic pneumonia, PJP) that has a specific treatment.
- Prolonged recruitment maneuvers (staircase) — harm in ART trial.
- Forgetting VAP, pneumothorax, and acute cor pulmonale as causes of deterioration.
Board corner
⌄
| Stem | Answer |
|---|---|
| Sepsis day 2, bilateral infiltrates, P/F 140 on PEEP 10, normal echo | Moderate ARDS |
| Best evidence-based ventilation strategy | Vt 6 mL/kg PBW, plateau ≤30 |
| ARDS, P/F 90 on FiO₂ 0.8, PEEP 14 | Prone positioning |
| Hypoxemia not improving with 100% O₂ | Shunt — needs PEEP/recruitment |
| Peak 45, plateau 22 | Airway resistance (mucus plug, kink, bronchospasm) |
| Peak 45, plateau 38 | Low compliance / pneumothorax |
| Bilateral infiltrates within 6 h of transfusion, no volume overload | TRALI |
| Smoker started recently, BAL eosinophils 40% | Acute eosinophilic pneumonia → steroids |
| Which therapy improves oxygenation but NOT survival? | Inhaled nitric oxide |
References
⌄
- ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526.
- Matthay MA, et al. A new global definition of ARDS. Am J Respir Crit Care Med. 2024;209:37.
- Qadir N, et al. An Update on Management of Adult Patients with ARDS: An Official ATS Clinical Practice Guideline. Am J Respir Crit Care Med. 2024;209:24.
- ARDS Network. Lower tidal volumes. NEJM. 2000;342:1301.
- Guérin C, et al. PROSEVA. NEJM. 2013;368:2159.
- Combes A, et al. EOLIA (ECMO). NEJM. 2018;378:1965.
- Villar J, et al. DEXA-ARDS. Lancet Respir Med. 2020;8:267.
- Wiedemann HP, et al. FACTT (fluids). NEJM. 2006;354:2564.
- Amato MBP, et al. Driving pressure and survival. NEJM. 2015;372:747.
- Gattinoni L, Pesenti A. The concept of "baby lung." Intensive Care Med. 2005;31:776.